Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01391156Phase 3Completed
Phase 3, randomised, double-blind trial of DA-4001C in androgenetic alopecia (AGA) (2 arms), sponsored by Mae Fah Luang University Hospital. Primary endpoint: Mean change of hair count at 6 months. Started Mar 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01391156.